Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Enfusion Q3 EPS $0.02 Misses $0.05 Estimate, Sales $44.36M Beat $44.05M Estimate

Author: Benzinga Newsdesk | November 07, 2023 08:39am
Enfusion (NYSE:ENFN) reported quarterly earnings of $0.02 per share which missed the analyst consensus estimate of $0.05 by 60 percent. This is unchanged from the same period last year. The company reported quarterly sales of $44.36 million which beat the analyst consensus estimate of $44.05 million by 0.70 percent. This is a 13.30 percent increase over sales of $39.15 million the same period last year.

Posted In: ENFN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist